WallStSmart

Cigna Corp (CI)vsFox Corp Class A (FOXA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cigna Corp generates 1615% more annual revenue ($277.89B vs $16.20B). FOXA leads profitability with a 10.6% profit margin vs 2.3%. CI appears more attractively valued with a PEG of 0.88. CI earns a higher WallStSmart Score of 68/100 (B-).

CI

Strong Buy

68

out of 100

Grade: B-

Growth: 6.7Profit: 5.5Value: 9.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.50

FOXA

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 7.5Value: 4.7Quality: 7.0
Piotroski: 5/9Altman Z: 2.44
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CIUndervalued (+57.1%)

Margin of Safety

+57.1%

Fair Value

$680.85

Current Price

$289.48

$391.37 discount

UndervaluedFair: $680.85Overvalued
FOXAOvervalued (-12.7%)

Margin of Safety

-12.7%

Fair Value

$48.60

Current Price

$65.54

$16.94 premium

UndervaluedFair: $48.60Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CI5 strengths · Avg: 8.6/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Market CapQuality
$77.73B9/10

Large-cap with strong market position

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
29.1%8/10

Earnings expanding 29.1% YoY

FOXA4 strengths · Avg: 8.0/10
P/E RatioValuation
17.3x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
21.4%8/10

Strong operational efficiency at 21.4%

Free Cash FlowQuality
$1.77B8/10

Generating 1.8B in free cash flow

Areas to Watch

CI2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.6%4/10

4.6% revenue growth

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

FOXA3 concerns · Avg: 2.0/10
PEG RatioValuation
29.002/10

Expensive relative to growth rate

Revenue GrowthGrowth
-8.6%2/10

Revenue declined 8.6%

EPS GrowthGrowth
-49.3%2/10

Earnings declined 49.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CI

The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : FOXA

The strongest argument for FOXA centers on P/E Ratio, Price/Book, Operating Margin.

Bear Case : CI

The primary concerns for CI are Revenue Growth, Profit Margin. Thin 2.3% margins leave little buffer for downturns.

Bear Case : FOXA

The primary concerns for FOXA are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

CI profiles as a value stock while FOXA is a declining play — different risk/reward profiles.

FOXA carries more volatility with a beta of 0.52 — expect wider price swings.

CI is growing revenue faster at 4.6% — sustainability is the question.

FOXA generates stronger free cash flow (1.8B), providing more financial flexibility.

Bottom Line

CI scores higher overall (68/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cigna Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).

Visit Website →

Fox Corp Class A

COMMUNICATION SERVICES · ENTERTAINMENT · USA

Fox Corporation is an American mass media company headquartered in New York City.

Visit Website →

Want to dig deeper into these stocks?